Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans Transplantation | 9 | 2014 | 31 | 0.750 |
Why?
|
| Transplantation | 2 | 2021 | 27 | 0.720 |
Why?
|
| Data Mining | 1 | 2021 | 59 | 0.680 |
Why?
|
| Kidney Transplantation | 9 | 2016 | 574 | 0.660 |
Why?
|
| Machine Learning | 1 | 2021 | 348 | 0.540 |
Why?
|
| Pancreas Transplantation | 5 | 2014 | 31 | 0.520 |
Why?
|
| Pancreatic Neoplasms | 6 | 2019 | 735 | 0.490 |
Why?
|
| Pancreatectomy | 6 | 2012 | 151 | 0.460 |
Why?
|
| Biomedical Research | 1 | 2021 | 554 | 0.460 |
Why?
|
| Graft Survival | 7 | 2016 | 482 | 0.450 |
Why?
|
| Liver Transplantation | 8 | 2019 | 1103 | 0.450 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2019 | 106 | 0.340 |
Why?
|
| Graft Rejection | 5 | 2016 | 566 | 0.300 |
Why?
|
| Living Donors | 4 | 2013 | 116 | 0.270 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 275 | 0.270 |
Why?
|
| Pancreatitis, Chronic | 3 | 2012 | 76 | 0.240 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 674 | 0.230 |
Why?
|
| Mycobacterium Infections | 1 | 2005 | 32 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 169 | 0.220 |
Why?
|
| Hepatectomy | 2 | 2019 | 124 | 0.210 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3171 | 0.210 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2023 | 130 | 0.210 |
Why?
|
| Interleukin-8 | 1 | 2023 | 214 | 0.200 |
Why?
|
| Liver Failure | 2 | 2013 | 91 | 0.190 |
Why?
|
| Pancreas | 2 | 2014 | 230 | 0.190 |
Why?
|
| Transplant Recipients | 2 | 2019 | 226 | 0.160 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2019 | 34 | 0.160 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 85 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 49 | 0.150 |
Why?
|
| Liver | 3 | 2019 | 1852 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 65 | 0.150 |
Why?
|
| Platelet Count | 1 | 2019 | 141 | 0.150 |
Why?
|
| Pancreatitis | 2 | 2014 | 142 | 0.150 |
Why?
|
| Tissue Donors | 2 | 2019 | 507 | 0.140 |
Why?
|
| Middle Aged | 20 | 2019 | 29020 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2021 | 1244 | 0.140 |
Why?
|
| Peanut Hypersensitivity | 1 | 2019 | 84 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 404 | 0.130 |
Why?
|
| Cell Separation | 2 | 2014 | 231 | 0.130 |
Why?
|
| Balamuthia mandrillaris | 1 | 2016 | 1 | 0.130 |
Why?
|
| Amebiasis | 1 | 2016 | 11 | 0.130 |
Why?
|
| Humans | 37 | 2023 | 133202 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 450 | 0.120 |
Why?
|
| Antilymphocyte Serum | 1 | 2016 | 42 | 0.120 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 18 | 0.120 |
Why?
|
| Islets of Langerhans | 2 | 2014 | 178 | 0.120 |
Why?
|
| Bile Ducts | 1 | 2015 | 54 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 106 | 0.120 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 44 | 0.120 |
Why?
|
| Encephalitis | 1 | 2016 | 122 | 0.110 |
Why?
|
| Adult | 18 | 2019 | 31742 | 0.110 |
Why?
|
| Carboxyhemoglobin | 1 | 2014 | 10 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 267 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 30 | 0.110 |
Why?
|
| Enzymes | 1 | 2014 | 45 | 0.110 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 63 | 0.110 |
Why?
|
| Gallstones | 1 | 2014 | 19 | 0.110 |
Why?
|
| Female | 25 | 2019 | 71456 | 0.110 |
Why?
|
| Fibrinolysis | 1 | 2014 | 44 | 0.110 |
Why?
|
| Thrombelastography | 1 | 2014 | 60 | 0.110 |
Why?
|
| Drug Resistance, Viral | 1 | 2013 | 48 | 0.100 |
Why?
|
| Male | 22 | 2019 | 65411 | 0.100 |
Why?
|
| Reoperation | 2 | 2013 | 856 | 0.100 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2014 | 121 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2015 | 374 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 255 | 0.100 |
Why?
|
| Analgesia, Epidural | 1 | 2012 | 29 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 239 | 0.100 |
Why?
|
| Cytomegalovirus | 1 | 2013 | 268 | 0.100 |
Why?
|
| Swine | 3 | 2014 | 1199 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 1 | 2013 | 226 | 0.090 |
Why?
|
| Young Adult | 10 | 2014 | 9973 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2012 | 181 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2013 | 393 | 0.090 |
Why?
|
| Retrospective Studies | 11 | 2019 | 17493 | 0.090 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2010 | 37 | 0.090 |
Why?
|
| Robotics | 1 | 2012 | 110 | 0.080 |
Why?
|
| Survival Rate | 5 | 2013 | 2198 | 0.080 |
Why?
|
| Aged | 11 | 2019 | 21480 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2012 | 313 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 1 | 2013 | 248 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 996 | 0.080 |
Why?
|
| Inpatients | 1 | 2013 | 552 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2012 | 520 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 288 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1402 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2012 | 387 | 0.070 |
Why?
|
| Risk Factors | 6 | 2015 | 10935 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5448 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2010 | 206 | 0.070 |
Why?
|
| Intestines | 1 | 2011 | 613 | 0.070 |
Why?
|
| Diabetes Mellitus | 3 | 2011 | 917 | 0.070 |
Why?
|
| Patient Selection | 3 | 2019 | 731 | 0.060 |
Why?
|
| Transplantation, Autologous | 3 | 2012 | 288 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2006 | 54 | 0.060 |
Why?
|
| Obesity | 2 | 2015 | 2419 | 0.060 |
Why?
|
| Macaca | 1 | 2006 | 63 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 1456 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3869 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 13069 | 0.060 |
Why?
|
| Child, Preschool | 6 | 2016 | 14906 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 147 | 0.060 |
Why?
|
| Cystadenoma, Papillary | 1 | 2004 | 4 | 0.060 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2004 | 5 | 0.050 |
Why?
|
| Giant Cell Tumors | 1 | 2004 | 5 | 0.050 |
Why?
|
| Prognosis | 4 | 2019 | 5043 | 0.050 |
Why?
|
| Breast Neoplasms, Male | 1 | 2004 | 16 | 0.050 |
Why?
|
| General Surgery | 1 | 2006 | 220 | 0.050 |
Why?
|
| Fibroma | 1 | 2004 | 31 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2023 | 77 | 0.050 |
Why?
|
| Exocytosis | 1 | 2023 | 66 | 0.050 |
Why?
|
| Internet | 1 | 2006 | 404 | 0.050 |
Why?
|
| Age Factors | 3 | 2015 | 2950 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2011 | 1251 | 0.050 |
Why?
|
| Child | 7 | 2016 | 25889 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2023 | 205 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 1135 | 0.050 |
Why?
|
| Software | 1 | 2006 | 731 | 0.050 |
Why?
|
| Animals | 8 | 2019 | 35916 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2006 | 566 | 0.040 |
Why?
|
| Time Factors | 3 | 2019 | 6526 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 536 | 0.040 |
Why?
|
| Organ Size | 2 | 2012 | 458 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 102 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2019 | 40 | 0.040 |
Why?
|
| Neoplasms | 1 | 2014 | 2975 | 0.040 |
Why?
|
| Skin Tests | 1 | 2019 | 80 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 189 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 446 | 0.040 |
Why?
|
| Adolescent | 6 | 2013 | 20594 | 0.040 |
Why?
|
| Cell Plasticity | 1 | 2019 | 35 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 180 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 808 | 0.030 |
Why?
|
| Cytokines | 1 | 2023 | 1374 | 0.030 |
Why?
|
| Length of Stay | 2 | 2013 | 1394 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 427 | 0.030 |
Why?
|
| Registries | 2 | 2014 | 1587 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 619 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 897 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2188 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 1013 | 0.030 |
Why?
|
| Arizona | 1 | 2015 | 27 | 0.030 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 17 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2013 | 8633 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 58 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 704 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1690 | 0.030 |
Why?
|
| Cholecystostomy | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 85 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2014 | 58 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 607 | 0.030 |
Why?
|
| APACHE | 1 | 2014 | 54 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 164 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2014 | 38 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2014 | 105 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 2014 | 63 | 0.030 |
Why?
|
| Ganciclovir | 1 | 2013 | 103 | 0.030 |
Why?
|
| Cold Ischemia | 1 | 2013 | 23 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 13 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2014 | 134 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2014 | 120 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 437 | 0.030 |
Why?
|
| Death | 1 | 2013 | 80 | 0.020 |
Why?
|
| United States | 3 | 2013 | 11658 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 541 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 13258 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 152 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2016 | 6579 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 560 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2012 | 66 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 593 | 0.020 |
Why?
|
| C-Peptide | 1 | 2012 | 116 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 40 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1653 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 161 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2015 | 408 | 0.020 |
Why?
|
| Viral Load | 1 | 2013 | 407 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2013 | 236 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 316 | 0.020 |
Why?
|
| Dissection | 1 | 2011 | 59 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3781 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2011 | 123 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 504 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 1169 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 193 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 718 | 0.020 |
Why?
|
| Antibody-Producing Cells | 1 | 2010 | 7 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2011 | 182 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2010 | 33 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 220 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2010 | 57 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 150 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1580 | 0.020 |
Why?
|
| Splenectomy | 1 | 2010 | 62 | 0.020 |
Why?
|
| Indians, North American | 1 | 2010 | 70 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 171 | 0.020 |
Why?
|
| Biliary Tract Diseases | 1 | 2009 | 37 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2012 | 279 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1262 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 480 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 767 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 344 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2010 | 151 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2011 | 240 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3409 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2009 | 82 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1852 | 0.020 |
Why?
|
| Antibodies | 1 | 2010 | 372 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2671 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 271 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 1173 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4848 | 0.020 |
Why?
|
| Portal System | 1 | 2006 | 36 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3094 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2007 | 313 | 0.010 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2006 | 167 | 0.010 |
Why?
|
| Thrombosis | 1 | 2009 | 543 | 0.010 |
Why?
|
| Gynecomastia | 1 | 2004 | 6 | 0.010 |
Why?
|
| Brain | 1 | 2016 | 3216 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2011 | 1069 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 1554 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 109 | 0.010 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2004 | 35 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 5175 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2585 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 18888 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 2745 | 0.010 |
Why?
|
| Curriculum | 1 | 2006 | 764 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 349 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 1237 | 0.010 |
Why?
|
| Quality of Life | 1 | 2007 | 2159 | 0.010 |
Why?
|